Cite

HARVARD Citation

    Labrador, J. et al. (2020). Dasatinib and FLAG-IDA Is an Effective Therapy for Initial Myeloid Blast Crisis but Involves a High Risk of Opportunistic Infections. Case reports in hematology. p. . [Online]. 
  
Back to record